Circulating endothelial progenitor cells in patients with ANCA-associated vasculitis

Kidney and Blood Pressure Research

Volumn 31, Issue 4, 2008, Pages 247-254

  Závada, Jakub ^a,b   Kideryová, Linda ^a   Pytlík, Robert ^a   Vaňková, Zdenka ^a   Tesař, Vladimír ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antineutrophil cytoplasmic antibody; Atherosclerosis; Endothelial progenitor cells; Hemodialysis; Vasculitis

Indexed keywords

AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; ATHEROSCLEROSIS; CELL COUNT; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; ENDOTHELIUM CELL; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FUNCTION; MALE; MICROVASCULATURE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REMISSION; STEM CELL; UREMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ATHEROSCLEROSIS; BLOOD CELLS; CELL COUNT; COLONY-FORMING UNITS ASSAY; CROSS-SECTIONAL STUDIES; ENDOTHELIAL CELLS; FEMALE; HEMOLYSIS; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; STEM CELLS; UREMIA; VASCULITIS;

EID: 51649098334     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000142690     Document Type: Article

References (18)

1. Woywodt A, Streiber F, de Groot K, et al: Circulating endothelial cells as markers for ANCA-associated small vessel vasculitis. Lancet 2003;361:206-210.
2. Holmén C, Elsheikh E, Stenvinkel P, et al: Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement. J Am Soc Nephrol 2005;16:3110-3120.
3. Brogan PA, Shah V, Brachet C, et al: Endothelial and platelet microparticles in vasculitis of the young. Arthritis Rheum 2004;50:927-936.
4. Jennette JC, Falk RJ, Andrassy K, et al: Nomenclature of systemic vasculitides - proposal of an international consensus conference. Arthritis Rheum 1994;37:187-192.
5. Hill JM, Zalos G, Halcox JP, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
6. Werner N, Kosiol S, Schiegl T, et al: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007.
7. Vasa M, Fichtlscherer S, Aicher A, et al: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-E7.
8. Levey AS, Grene T, Kusek JW, Beck GJ: A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol 2000;11:A0828.
9. Scheubel RJ, Yorn H, Silber R-E, et al: Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003;42:2073-2080.
10. Shaffer RG, Greene S, Arshi A, et al: Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations. Cytometry B Clin Cytom 2006;70B:56-62.
11. Chen M-C, Yip H-K, Chen C-J, et al: No age-related change in circulating endothelial progenitor cells in healthy subjects. Int Heart J 2006;47:95-105.
12. De Groot K, Bahlmann FH, Sowa J, et al: Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004;66:641-646.
13. Choi J, Wim KL, Wooseong H, et al: Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004;24:1246-1252.
14. Eizawa T, Murakami Y, Matsui K, et al: Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr Med Res Opin 2003;19:627-633.
15. Herbrig K, Pistrosch F, Foerster S, Gross P: Endothelial progenitor cells in chronic renal insufficiency. Kidney Blood Press Res 2006;29:24-31.
16. Butzal M, Loges S, Schweizer M, et al: Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro. Exp Cell Res 2004;300:65-71.
17. Bertolini F, Paul S, Mancuso P, et al: Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells. Cancer Res 2003;63:4342-4346.
18. Hogan SL, Falk RJ, Chin H, et al: Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 2005;143:621-631.